Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * | KEGG DRUG * | DrugBank | 指定難病告示番号 * |
1 | Calcium signaling pathway |
2件: EDNRA, EDNRB | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
2 | cAMP signaling pathway |
1件: EDNRA | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
3 | cGMP-PKG signaling pathway |
2件: EDNRA, EDNRB | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
4 | Cytokine-cytokine receptor interaction |
1件: EPOR | D03231 | Erythropoietin | 9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
5 | Hematopoietic cell lineage |
1件: EPOR | D03231 | Erythropoietin | 9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
6 | JAK-STAT signaling pathway |
1件: EPOR | D03231 | Erythropoietin | 9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
7 | Melanogenesis |
1件: EDNRB | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
8 | Neuroactive ligand-receptor interaction |
2件: EDNRA, EDNRB | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
9 | Pathways in cancer |
2件: EDNRA, EDNRB | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
1件: EPOR | D03231 | Erythropoietin | 9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 | ||
10 | PI3K-Akt signaling pathway |
1件: EPOR | D03231 | Erythropoietin | 9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
11 | Relaxin signaling pathway |
1件: EDNRB | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
12 | Renin secretion |
1件: EDNRA | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 | |||||
13 | Vascular smooth muscle contraction |
1件: EDNRA | D01227 | Bosentan | 10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |